ONLY $9.90 DELIVERY INFO

Close Notification

Your cart does not contain any items

$382.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
25 July 2025
Psychedelics in Psychiatry, Volume 181, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Chapters in this new volume include History of psychedelic drug science and molecular pharmacology, Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents, Anti-inflammatory activity, Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents, Clinical pharmacology, Human neuroimaging fMRI, and more.

Other chapters in this new release include Effects of psychedelics on human oscillatory brain activity, Molecular neuroimaging of psychedelic drug effects, Neurobiology of sub-psychedelic doses, Depression and related disorders, Addictions, Trauma disorders, Neurological disorders, and Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy.
Volume editor:   ,
Imprint:   Academic Press Inc
Country of Publication:   United States [Currently unable to ship to USA: see Shipping Info]
Dimensions:   Height: 229mm,  Width: 152mm, 
Weight:   450g
ISBN:   9780443343858
ISBN 10:   0443343853
Series:   International Review of Neurobiology
Pages:   442
Publication Date:  
Audience:   Professional and scholarly ,  College/higher education ,  Undergraduate ,  Further / Higher Education
Format:   Hardback
Publisher's Status:   Active
Section 1 1. History of psychedelic drug science and molecular pharmacology 2. Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents 3. Anti-inflammatory activity 4. Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents 5. Clinical pharmacology 6. Human neuroimaging fMRI 7. Effects of psychedelics on human oscillatory brain activity 8. Molecular neuroimaging of psychedelic drug effects 9. Neurobiology of sub-psychedelic doses Section 2 10. Depression and related disorders 11. Addictions 12. Trauma disorders 13. Neurological disorders Section 3 14. Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy

See Also